Bedoradrine

CAS No. 194785-19-8

Bedoradrine( —— )

Catalog No. M36323 CAS No. 194785-19-8

Bedoradrine (MN-221) free base is a novel, highly selective β2-adrenoceptor agonist for the treatment of asthma and chronic obstructive pulmonary disease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 1158 Get Quote
5MG 1511 Get Quote
25MG 2475 Get Quote
50MG 3110 Get Quote
100MG 4140 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Bedoradrine
  • Note
    Research use only, not for human use.
  • Brief Description
    Bedoradrine (MN-221) free base is a novel, highly selective β2-adrenoceptor agonist for the treatment of asthma and chronic obstructive pulmonary disease.
  • Description
    Bedoradrine (MN-221) free base is a novel, highly selective β2-adrenoceptor agonist for the treatment of asthma and chronic obstructive pulmonary disease.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    194785-19-8
  • Formula Weight
    428.52
  • Molecular Formula
    C24H32N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(C[C@H](O)C1=CC(CCO)=C(O)C=C1)[C@@H]2CC=3C(CC2)=CC=C(OCC(N(C)C)=O)C3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Acebutolol

    A cardioselective beta blocker for the treatment of hypertension and arrhythmias.

  • Midaglizole hydrochl...

    Midaglizole hydrochloride ((±)-DG5128) (DG5128) is a preferred α2-adrenoceptor antagonist. Midazolazole hydrochloride (DG5128) has an affinity for α2-adrenoceptor (pKi = 6.28) 7.4 times higher than that of α1-adrenoceptor.

  • (3aR,9aR)-Fluparoxan

    (3aR,9aR)-Fluparoxan is a highly selective and potent adrenergic receptor α2B antagonist for the prevention, amelioration or treatment of neurodevelopmental disorders and neurodegenerative diseases.